BLES Biochemicals Employee Directory

BLES Biochemicals Inc. is an established global player in providing innovative solutions for treating NRDS. With over 40 years of research and the development of BLES®, the leading pulmonary surfactant in Canada4, and now BLEScathTM , the company strives to provide interventions that expand the standard of care practices. The company's researchers... aim to complement existing practices and enhance neonatal care to alleviate NRDS-related mortality and morbidity. Many premature infants with NRDS may not have survived without treatment with an exogenous pulmonary surfactant, such as BLES®. The company believes that everyone deserves access to this therapy, and the company works hard to make that a reality around the world. The innovation of BLEScathTM results from a continued commitment to that mission. The company want to live in a world where every neonate with NRDS has access to life-saving pulmonary surfactant and associated delivery devices. Until this vision is realized, the company continue to serve the underserved.Read More